Close
  Indian J Med Microbiol
 

Figure 2: Clinical profile 10 weeks posttreatment (a) the occluded macular artery** and vein (arrow) are attenuated. (b and c) Early-phase fluorescein angiogram: No dye in superotemporal artery* and vein; delayed filling of macular artery** and loop. Late phase shows obliterated macular vein (white arrow) and retrograde flow in superotemporal vein (black arrow) from perfused areas. (d) Macular edema resolved; retinal opacification persists

Figure 2: Clinical profile 10 weeks posttreatment (a) the occluded macular artery** and vein (arrow) are attenuated. (b and c) Early-phase fluorescein angiogram: No dye in superotemporal artery* and vein; delayed filling of macular artery** and loop. Late phase shows obliterated macular vein (white arrow) and retrograde flow in superotemporal vein (black arrow) from perfused areas. (d) Macular edema resolved; retinal opacification persists